PLGA for Pulmonary Drug Delivery: Inhalable Microparticles, Dry Powder Formulation, and Regulatory Landscape
Introduction: PLGA for pulmonary drug delivery has become a focal point for formulators seeking to extend the therapeutic window of […]
Cell-Penetrating Peptides in Oligonucleotide Conjugates: Mechanisms, Sequences, and Design Rules
Introduction Cell-Penetrating Peptides in Oligonucleotide Conjugates are sophisticated chimeric macromolecules developed to address the significant challenge of poor cellular uptake
Characterization Methods for PLGA Microspheres: Particle Size, PDI, Encapsulation Efficiency, and In Vitro Release Testing
Introduction Characterization Methods for PLGA Microspheres involve a comprehensive range of advanced analytical techniques used to assess the physicochemical properties,
Metabolite Quantification in Bioanalysis: When Is It Required and How Is It Validated?
Introduction Metabolite quantification in bioanalysis plays an essential role throughout the drug development process by providing a definitive assessment of
Metabolite Quantification in Bioanalysis: When Is It Required and How Is It Validated? Read More »
Stability Testing in Bioanalysis: Freeze-Thaw, Bench-Top, and Long-Term Stability Under ICH M10
Introduction Stability testing in bioanalysis, as outlined in the ICH M10 guideline, provides scientific evidence that every stage of sample
Preservative-Free Dexamethasone Injection Development
Introduction: Dexamethasone Injection Development has become increasingly sophisticated as pharmaceutical companies pursue preservative-free injectable products designed to meet evolving clinical
Preservative-Free Dexamethasone Injection Development Read More »
Extractables & Leachables (E&L) Testing for Veterinary Drug Products and Packaging: VICH GL51 Compliance
Introduction Extractables & Leachables (E&L) Testing for Veterinary Drug Products is an essential safety and regulatory requirement designed to ensure
Comparability Exercise in Biosimilar Development: Design, Data Interpretation, and Regulatory Expectations
Introduction The design and implementation of a comparability exercise in biosimilar development represent the fundamental benchmark for demonstrating molecular similarity
NDSRI vs. Simple Nitrosamines: How Molecular Structure Determines Potency Classification and AI Limit
Introduction The primary technical consideration when comparing NDSRIs with simple nitrosamines lies in understanding how differences in molecular complexity and
Peptide Physicochemical Characterization Services: Solubility, pKa, Log P, and Stability Profiling
Introduction Peptide physicochemical characterization services establish the scientific basis required to confirm the molecular identity, therapeutic suitability, and regulatory compliance